Kazia Therapeutics names James Levine as CFO
Go back to Kazia Therapeutics names James Levine as CFO| (NASDAQ: KZIA) | Delayed: 12.59 -0.03 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.62 | 52 Week High | $ | |||
| Open | $12.80 | 52 Week Low | $ | |||
| Day High | $12.96 | P/E | N/A | |||
| Day Low | $12.40 | EPS | $ | |||
| Volume | 46,989 | |||||

